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A full-length cDNA clone encoding steroid 1 l&hydroxylase (P-450,,& has been isolated from a cDNA library derived from human adrenal tumor. 
The insert of the clone contains an open reading frame encoding a protein of 503 amino acid residues together with a 4 bp S-untranslated region 
and a 576 bp 3’-untranslated region to which a poly(A) tract is attached. The promoter region of the P-450118 gene has also been isolated from 
a genomic library derived from human pre-B cells. It contains a TATA box, a putative CAMP-responsive lement, several repeated sequences and 
two sequence lements imilar to the consensus equence for binding of AP-1. A transient expression assay in Y-l adrenal tumor cells demonstrates 
that the promoter activity is remarkably enhanced by treatment of the cells with CAMP. In addition, analysis using deletion mutants containing 
various lengths of the S-flanking region of the gene suggests that several &-acting elements participate in transcriptional regulation of human 
P-450118 gene. 
Monooxygenase; P-450,,~; cDNA; Genomic DNA, Adrenal tumor; Steroidogenesis 
1. INTRODUCTION 
Steroid 1 lo-hydroxylase (P-45011& a monoox- 
ygenase [11, is an adrenal-specific ytochrome P-450 re- 
quired for synthesis of both glucocorticoids and 
mineralocorticoids [2]. It has been shown that the en- 
zyme purified from bovine adrenocortical mitochon- 
dria catalyzes not only 1 lo-, 18- and 19-hydroxylations 
of 1 1-deoxycorticosterone but also the conversion of 
corticosterone to aldosterone via l%hydroxycorticos- 
terone [3-51. Clinical importance of human P-45011~ is
evident because 5-8070 of reported cases of congenital 
adrenal hyperplasia are caused by a defect of 11/3- 
hydroxylation [6]. 
we made an effort to isolate a genomic DNA clone to 
elucidate the regulatory mechanisms of expression of 
the corresponding gene. 
In this paper, we report the nucleotide sequence of a 
full-length human P-450110 cDNA and that of the pro- 
moter region of the gene. Also, we present a line of 
evidence to show that the promoter region of human 
P-450118 gene contains several &-acting elements and 
that the gene expression is tissue-specifically regulable 
by CAMP at least in a cultured cell system. 
2. MATERIALS AND METHODS 
Recently, a cDNA clone containing a partial-length 
insert encoding human P-4501 ~ has been isolated from 
a fetal adrenal cDNA library and its nucleotide se- 
quence determined [7]. More recently, a human 
genomic DNA for P-450116 has been isolated and se- 
quenced [8]. Nevertheless, a complete nucleotide se- 
quence of human P-4501 10 cDNA is not as yet definitely 
determined, although it is deduced by comparing the 
nucleotide sequence of human genomic DNA [8] with 
those of a partial-length human cDNA [7] and full- 
length bovine cDNAs [7,9,10]. In addition, how expres- 
sion of human P-450116 gene is regulated in living cells 
remains to be elucidated. Therefore, we attempted to 
isolate a full-length clone to define the entire nucleotide 
sequence of human P-450110 cDNA. Simultaneously, 
2.1. Molecular cloning and nucleotide sequencing 
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Total human RNA was prepared as described by Chirgwin et al. 
[ll] from adrenal tumor of a patient suffering from primary 
aldosteronism. Poly(A)+ RNA was enriched therefrom by oligo(dT)- 
cellulose chromatography [ 121. cDNA produced from the poly(A) + 
RNA was fractionated by gel filtration and cDNA species longer than 
1 kb were collected and used to construct a &tlO cDNA library as 
described by Huynh et al. [ 131. A full-length cDNA clone was isolated 
out of 1.3 x lo6 recombinants using as a probe the 45-mer synthetic 
oligonucleotide 
(5 ‘-GGGCACGTGGTAGAAGTTCCTGCCGGAGCCCTTGATG- 
TCTAGCCA-3 ‘) of which 5 ’ end was labeled with [y-‘*P]ATP and 
polynucleotide kinase. The probe was designed on the basis of the 
nucleotide sequence of a partial-length human P-45011~ cDNA [7]. 
The insert of the cDNA thus isolated was subcloned into pUC plasmid 
for further analysis. Nucleotide sequence was determined by the 
dideoxy chain termination method [14,15]. A genomic clone was 
isolated from a human genomic library which was derived from pre-B 
cells and packed in cosmid Lorist 2 vector. The total length of the in- 
sert was = 40 kb, but the 1.4 kb HindHI-Smal fragment containing 
the promoter region of the P-45011,s gene was subcloned into pUCll9 
plasmid and used for further studies. 
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Fig. 1. Restriction map of and 
restriction endonuclease sites. 
sequencing strategy for the cloned cDNA encoding human P-450 rrg. The restriction map displays 
A closed box and a solid line represent he protein coding region and the untranslated regions, 
Horizontal arrows show the direction and the extent of sequence determination. 
5'---T&A 
ATGGCACTCAGGGCAAAGGCAWIGGTGTGCA'IGGCAGTGC 
~etmaLeuArgAlaLysAlaGluVa1C~~~tAlaValProTrpLeuSerLeuG1nA~~laGlnAlaLeu lyThrArgAlaAlaA;~ValProArgThrV~ILeuProPhc6luA~; 
1 f 
GTGGATGCAGTGGCCAGGGACTTCTCCCA66CCCTGAAGAAGAAGGTGCTGCA611ACGCC6~~~CT~CCCT6~CGTCC~CCA~ATC~C~T~AC~T~C~~ 
ValAspAlaValAlaArgAspPheSerG1nAlaLeuLysLysLysValLeuGlnAsnAlaArg6lySerLeuThrLeuAspValGlnPro~rIlePheHisTyrThrIl~l~la~r 
170 190 190 290 
AACTTGGCTCTTTTTGGAGAGCGGCTGGGCCTGGTfGGCCAC~CCCCA6TTCT~C~CT~CTTCCTCCAT~CCT~~T~T6~C~TCCACC6TC~T~T~~T6 
AsnLeuAlaLeuPheGlyG1uArgLeu~~i;LeuValG1yHisSerProSerSerAlaSerLeuAsnPheLeuHlsAlaLeuGluVal~tPhcLysSerThrVal6lnLe~tPh~~ 
220 230 
CCCAGGA6CCT6TCTCGCT6GACCA6CCCC~GGTGTGGACTTC 
ProArgSerLeuSerArgTrpThrSerProLysValTrpLysGluH~s?heGluAlaTrpAspCysIlePhe61nTyrGlyAspAsnCysIle6lrrLysIleTyffi1n6luLeuAlaPhe 
250 260 270 290 
TTTCCCTTGCTGATGACGCTCTTTGAGCTGGCTCGGAACCCCAGCCTGGCCGCCGCAGCCAGCATCAGTGAACATCCCCAGAA66CCACC 
PheProLeuLeuMetThrLeuPheG1uLeuAlaArgAsnProAsnValG1nG1nAlaLeuArgG1nG1uSerLeuAlaAlaAlaAlaSerIleSeffi1uHlsProGlnLysAlaThr~~~ 
330 340 350 
ACATTGGTGCGCGTGTTCCTCTACTCTCTGGGTCGCAACCCCGCCTTGTTCCCGAGGCTTCTACCAC 
ThrLeuVa1ArgVa1PheLeuTyrSerLeu6lyArgAsnProAlaLeuPheProArgProGluArgTyrAsnPro6lnArgTrpLeu~~~IleArg6lySerGlyArgAsnPheTy*Hls 
410 420 440 
490 500 
TGCCTGACCCCAGGCCACCCCTCTTCTCTCCCACAT6CACAGtTTCCTGA6TCACCCCTCTGTCTACCAGCCCCAGCACAAATGGAACTCCC~~6CCTCTA~CCA~6T~GCCA 
GGCTMGCAGCAATGCCAGGGCACAGCTGGGGAAGATCTTGCT~CCTTGTCCCCAGCCCCACCTGGCCCTTTCTCCAGC~GCACTGTCCTCTG~CAGTTTGCCCCCATCCCTCCCAG 
TGCTGGCTCCAGGCTCCTCGTGTGGCCATGCAAGGGTGCTGTGGTTTTGTCCCTTGCCTTCCTGCCTAGTCTCACATGTCCCTGTTCCTCTTCCCCTGGCCAGGGCCCCTGCGCAGACT6 
TCAGAGTCATTAAGCGGGATCCCAGCATCTCAGAGTCCAGTCAAGTTCCCTCCTGCAGCCTGCCCCCTAGGCAGCTCOIGCATGCCCTGAGCTCTCTGAAAGTTGTCGCCCTG~TA~ 
GTCCTGCAGGGTA~~AGGCCCCTGTGGTCACTTGTCCTGAAAAMAAAA-----3 
only relevant 
respectively. 
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Fig. 2. Nucleotide sequence of human P-450 I18 cDNA and deduced amino acid sequence. Nucleotides are numbered starting at the first nucleotide 
of the translationai initiation codon ATG. The deduced amino acid sequence is shown below the nucleotide sequence and amino acid residues are 
numbered beginning with the initiative methionine. A star symbol downstream of the protein coding region indicates the stop codon. The cleavage 
site for human P-450rre precursor polypeptide to form a mature protein is tentatively assigned to be between Leu-24 and Gly-25 and indicated by 
an arrowhead in the figure, because the same position is also postulated to be the cleavage site of bovine P-45011,r p ecursor protein [7,9]. The 
amino acid sequence shown by an underline represents the putative heme binding site. The poly(A) addition signal is marked by a double 
underlining. 
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2.2. DNA transfection and chloramphenicol acetyltransferase (CAT) 
assay 
To obtain various deletion mutants fused to the bacterial CAT 
gene, the clone containing the NindIII-SmaI fragment as described 
above was linearized with HindIII. treated with Ba131 exonuclease 
and then digested with EcoRI. The resulting fragments were subclon- 
ed into pUC118 plasmid and endpoints of various deletion mutants 
thus produced were determined by nucleotide sequencing. The insert 
of each deletion mutant was excised drom pUC118 plasmid and in- 
serted into the Hind111 site of pSVOOCAT [16] after ligated with a 
Hind111 linker. 
Y-l adrenal tumor cells [17] supplied from Japanese Cancer 
Research Resources Bank were cultured in Ham’s F-12K medium sup- 
plemented with 15% fetal bovine serum (FBS). HeLa cells were 
cultured in Dulbecco’s modified Eagle’s medium supplemented with 
10% FBS. The cells were plated at 3 x lo6 for Y-1 cells or at 1 x 10’ 
cells for HeLa cells per 90-mm dish, and cultured for 24 h. They were 
then transfected with CAT plasmids by the calcium phosphate-DNA 
coprecipitation method [18] followed by glycerol shock. CAT assays 
were performed according to the method of Got-man et al. [19]. In 
some experiments after DNA transfection, the cells were incubated in 
the culture medium supplemented with 1 mM 8-bromoadenosine 
3 ’ 5 ‘-cyclic monophosphate (8-Br CAMP). 
3. RESULTS 
Fig. 1 represents the restriction map of and the se- 
quencing strategy for the full-length insert (pH1 l@l) of 
the cDNA clone isolated. Fig. 2 shows the nucleotide se- 
quence of pH1 l/31 consisting of 2089 bp excluding a po- 
ly(A) tract. The translational initiation site is assigned 
to be the first ATG codon, because the transcriptional 
initiation site of the P-450110 gene is the nucleotide C, 7 
bp upstream from the ATG codon (Fig. 3). Also, the se- 
quence around the first ATG triplet agrees well with the 
favoured sequence which flanks the functional initia- 
tion codon &XXATG, where X is any nucleotide [20]. 
The open reading frame starting from this initiation 
codon consists of 1509 nucleotides encoding a polypep- 
tide composed of 503 amino acid residues, followed by 
the translational termination codon TAA. A poly(A) 
tract is attached to the 3 ‘-terminus of 576 bp 
3 ‘-untranslated region. The amino acid sequence 
-1324 
5’_____MAGt_ 
-1093 
-1200 -1190 -1180 -1170 -1160 -1150 -1140 -1130 -1120 -1110 -1100 -Gz 
ATCAGGATGATGCTGGCCTCATAAAATGAGTTAGG~G~TTCCCTCTCTTTCTATT~TTG~TAGTTTCA~GG~TGGTACCAGTTCCTCCTTGTACGTCTGGTAT~TTCGGCT 
-1080 -1070 -1060 -1050 -1040 -1030 -1020 -1010 -1000 -990 -980 
GTGAATCCATCTGGTCATGCTCTTTTTGG~GGT~TCTA~~TTATTGCCAC~TTTCA~TCCTGTTATTGGTCTATTCA~~TTC~CTTCTTACTGGTT~~~~CTT~~~ 
-960 -950 -940 -930 -920 -910 -900 -890 -880 -870 -860 
GTGTATGTGTCGAGWATrrATCCATTTCTTCTAGATTTTTATTTGCGTA~GGTGTTTGTAGTATTCTCT~TGGTAGTTTGTATTTCTGTGG~TCGGT~~~~TATCCCCT 
F 
-840 -830 -820 -810 -800 -790 -780 -770 -740 
TTATCATTTTTTATTGCATCTATTTGATTCTTCTCTCTT~TTTCTTTATTAGTCTTGCTAGCGGTCTATC~TTTTGTTGATCCTTTC~~CCAGCTCCTG~~~~~TT~TTTTT 
-720 -710 -700 -690 -680 -670 -660 -650 -640 -630 -620 
TW\AGGGTTTTTTGTGTCTCTATTTCCTTCAGTTCTGCACT~TTTTAGTTATTTCTTGCCTTCTGCTAG~TT~TGTGTTTGCTCTTGCTTTTCTAGTTCTTTT~~~GT~TGTTA 
-----_______* 
-505 
-600 -590 -580 -570 -560 -550 -540 -530 -520 -510 1 -490 
GGGTGTCAGTTTTGGATCTTTCCTGCTTTCTCTTGTGGGCATTTAGTGCTAT~TTTCCCTCTACACACTGCTTT~TGTGTTCCA~~TTCTGGTATGCTGTGTCTTTGTTCTCGl 
____________* 
-480 -470 -460 -450 -440 -430 -420 -410 -400 -390 -380 
TGGTTTCAAGAACATCTTTATTTCTGCCTTCATTTTGTTACCCAGTAGTCATTCAGGAGCAGGTTGCTCAGTTTCCATGTAATT~GCGGTTTT~GT~G~~~~~~TCCT~G 
-704 - - __ 1 
-360 -350 -340 -330 -320 -310 -300 1-290 -280 -270 -260 -250 
TTCTAGTTTGATTGCACTAMATTTTTAAAAAGTM TACATGTGGTTTAATACAATTCATGCCAACTCATTCCCTCGTTTTTTGCTAT~CCTTGC~~~T~T~TCC 
-240 -230 -220 -210 -200 -190 -180 -170 -160 -150 -140 
AAGGCTCTTG~TAAGATM666CCCCATCCATCTTGCTCCTCTCAGCCCTG~~GGAGG~~GTCCTTTTCCCCTGTCTACGCTCATGCACCCC~T~GTC~~~~CTCCAGCC 
-105 -47 
-120 -110 Gi -90 -80 -70 -60 -50 140 
CTGACCTCTGCCCTCGGTCTCTCAGGCAsATCCAGGGCCAGTTCTCCCAT~CGT~TCCCTCCC~GGC~GGCACCAGGCA T ~~~~TTGEET~CA,~T~GG~G 
'E 
+10 +20 l 30 +40 l 50 +60 +70 +80 +90 
ATTG(iMTGGCACTCAGGGCAAA66CA6AGGTGT~ATG~AGTGCCCTG~TGTCCCTGC~A~~ACAGGCACTGGGCAC~~GCC~CCG~-----3' 
lrktAlaLeuArgAlaLysAlaG1uValCys~tAlaValProTrpLeuSerLeuGlnArgAlaG1nAlaLeuGlyThrArgAlaAlaArg------ 
Fig. 3. Nucleotide sequence of the 5’-flanking region and exon I of the P-4501~0 gene. Numbers above the nucleotide sequence refer to nucleotide 
positions relative to the transcriptional initiation site taken as + 1 [8]. The deduced amino acid sequence is shown below the nucleotide sequence. 
A TATA element is boxed, and putative CAMP-responsive and AP-1 elements are shown by double and single underlines. respectively. Palindromic 
and two types of repeated sequences are indicated by solid and dashed arrows with open and closed arrowheads, respectively. The endpoints of 
5’-deletion mutants used for transient expression assays in Fig. 4 are also shown by solid broken arrows. 
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Fig. 4. Transient expression assay of the P-45011s gene. (A) Structures of 5’-deletion mutants used in these experiments are depicted. Numbers 
on the left of diagrams indicate the 5’-endpoints of deletion mutants. (B) Cyclic AMP-inducible expression of the P-450114 gene. Y-1 cells were 
transfected with the chimeric construct, pl lflCAT1093, or the @actin-CAT construct, pj3ACCAT. They were incubated in the absence (- ) or 
presence (+) of 1 mM 8-Br CAMP for 40 h. Percentages of chloramphenicol conversion to its acetylated erivatives and induction rates are shown 
by numerals in the figure. (C) Analysis of promoter activity of 5’-deletion mutants. Y-l or HeLa cells were transfected with various deletion 
mutants and incubated in the medium supplemented with 1 mM 8-Br CAMP for 40 h. Then, CAT activities were measured as described [19]. 
deduced from the nucleotide sequence of pH1 l/31 (Fig. 
2) is strikingly homologous to those of bovine [7,9,10] 
and rat [21] cDNAs for P-45011,3 (73% homologous 
with the bovine amino acid sequence and 64% 
homologous with the rat amino acid sequence; un- 
published results). 
Using the same oligonucleotide probe as that used for 
screening the cDNA library, we simultaneously isolated 
a genomic clone containing the 5 ‘-flanking region of 
the gene. As shown in Fig. 3, nucleotide sequence 
analysis reveals that the region contains a TATA box 
(- 35 to - 29), a putative CAMP-responsive element, 
CRE, (- 71 to - 64) [22] and two putative AP-1 
elements (- 383 to - 377 and - 139 to - 133) [23,24]. 
It is noticed that two types of repeated sequences and a 
palindromic sequence are present in the region shown in 
Fig. 3. 
In the next experiments, we examined whether the 
promoter is responsive to chemical stimuli such as 
CAMP by using CAT assay. As shown in Fig. 4, treat- 
ment of Y-l cells with 8-Br CAMP results in a marked 
348 
increase in promoter activity up to 11-fold when a 
chimeric construct containing the 5 ’ -flanking region up 
to - 1093 relative to the transcriptional initiation site is 
used. In contrast, the same treatment has substantially 
no effect on the transient expression of a human p- 
actin-CAT construct, p/3ACCAT [25]. 
In order to localize &-acting element(s) in the 
5 ’ -flanking region, promoter activities of various 
5 ’ -deletion mutants were measured by transient expres- 
sion assays (Fig. 4). When the region between - 1324 
and - 1094 is deleted, promoter activity increases 
4-fold, suggesting that the region between - 1324 and 
- 1094 contains negative &acting element(s). On the 
other hand, further deletion extending to position 
- 761 causes a marked reduction of promoter activity, 
indicating that the region between - 1093 and -761 is 
required for efficient transcriptional activity. A further 
decrease in the activity occurs when the 5’-flanking 
region is deleted to position - 506. Finally, deletion to 
position -295 results in a considerable loss of pro- 
moter activity. When HeLa cells are used in place of 
Volume 269, number 2 FEBS LETTERS September 1990 
Y-l adrenal cells, no promoter activity is detectable 
(Fig. 4C), suggesting that expression of human P-450110 
gene is highly tissue-specific. 
The above results, taken together, indicate that the 
5 ’ -flanking region of the gene we isolated has promoter 
activity and that the promoter region has various cis- 
acting elements which might participate in regulating 
expression of human P-450118. 
4. DISCUSSION 
In the present study, we have isolated a full-length 
cDNA for human P-450110 and simultaneously a 
genomic .DNA having the promoter region of the 
P-45Orre gene. As a whole, our nucleotide sequence 
data of the cDNA agree well with those deduced from 
human genomic DNA for P-450110 [8], although minor 
differences are detectable. Differences of the nucleotide 
sequences are more marked when our data of a full- 
length cDNA are compared with those of a partial- 
length cDNA [7]. The minor differences between the 
former data [8] and ours are probably due to allelic 
variants, but the reason for considerable differences 
between the latter data [7] and ours is unclear. 
Promoter activity of human P-450118 gene is marked- 
ly enhanced by treatment of Y-l cells with CAMP (Fig. 
4B) as is observed with mouse P-45Orr~ gene [26]. It is 
noted that the chimeric construct (pl l@CATlOS, in Fig. 
4C) contains a CRE-like element and yet it does not ex- 
hibit any detectable promoter activity even after treat- 
ment of the cells with CAMP. Nevertheless, this CRE- 
like element may be involved at least in part in 
transcription of human P-450110 gene, because muta- 
tion of the CRE present in mouse P-45011~ gene 
abolishes the gene expression [27]. Whether various 
elements present in the 5 ‘-flanking region of human 
P-45011~ gene exhibit any regulatory significance in liv- 
ing cells must wait for further study. 
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